Abdullaeva S, Chubarev V, Valeeva A, Preferanskaya N, Neganova M, Smolyarchuk E, Liu J, Sukocheva O, Samsonov M, Alyautdin R (2025) Analysis of clinical success and molecular mechanisms of action of novel anti-glioblastoma drugs: a review. Curr Med Chem 32(6):1082–1102. https://doi.org/10.2174/0109298673281283240101053940

Article  CAS  PubMed  Google Scholar 

Agrawal P, Gautam A, Prakash C, Garg R, Pursnani N, Yadav S, Panda S, Sharma S, Dantu R (2025) Safety and efficacy of Imeglimin in type 2 diabetes individuals with Metformin intolerance: a case-control study. Clin Diabetol 14(3):154–162. https://doi.org/10.5603/cd.104962

Article  Google Scholar 

Akbar M, Essa MM, Daradkeh G, Abdelmegeed MA, Choi Y, Mahmood L, Song B-J (2016) Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress. Brain Res 1637:34–55

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhowail A, Aldubayan M (2021) Recent progress in the Elucidation of the mechanisms of chemotherapy-induced cognitive impairment. Eur Rev Med Pharmacol Sci 25:18

Google Scholar 

Ang J-J, Low B-S, Wong P-F (2024) Dopamine and central dopaminergic circuitry in neurodegenerative diseases: roles and mechanisms of action of natural phytochemicals. Pharmacol Res. https://doi.org/10.1016/j.prenap.2024.100050

Article  Google Scholar 

Archie SR, Al Shoyaib A, Cucullo L (2021) Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13111779

Article  PubMed  PubMed Central  Google Scholar 

Asha Spandana KM, Bhaskaran M, Karri VVSNR, Natarajan J (2020) A comprehensive review of nano drug delivery system in the treatment of CNS disorders. Journal of Drug Delivery Science and Technology 57:101628. https://doi.org/10.1016/j.jddst.2020.101628

Article  CAS  Google Scholar 

Atabi F, Moassesfar M, Nakhaie T, Bagherian M, Hosseinpour N, Hashemi M (2025) A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer’s disease. Diabetol Metab Syndr 17(1):356. https://doi.org/10.1186/s13098-025-01930-2

Article  PubMed  PubMed Central  Google Scholar 

Ataei M, Abdollahi M (2022) A systematic review of mechanistic studies on the relationship between pesticide exposure and cancer induction. Toxicol Appl Pharmacol 456:116280. https://doi.org/10.1016/j.taap.2022.116280

Article  CAS  PubMed  Google Scholar 

Babu A, Urulangodi M (2023) Chemotherapy-induced neuronal DNA damage: an intriguing toolbox to elucidate DNA repair mechanisms in the brain. Genome Instability Disease 4(6):315–332

Article  CAS  Google Scholar 

Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K (2019) Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56(10):7159–7172. https://doi.org/10.1007/s12035-019-1589-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banks WA, Rhea EM, Reed MJ, Erickson MA (2024) The penetration of therapeutics across the blood-brain barrier: classic case studies and clinical implications. Cell Rep Med 5(11):101760. https://doi.org/10.1016/j.xcrm.2024.101760

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbaro M, Fine HA, Magge RS (2021) Foundations of neuro-oncology: a multidisciplinary approach. World Neurosurg 151:392–401

Article  PubMed  Google Scholar 

Barbosa F, Cunha A, Barbosa J, Faria J, Queirós O (2025) The dual role of Metformin: repurposing an antidiabetic drug for cancer therapy. Appl Sci 15(21):11576

Article  CAS  Google Scholar 

Benet LZ, Bowman CM, Koleske ML, Rinaldi CL, Sodhi JK (2019) Understanding drug–drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs. J Pharmacokinet Pharmacodyn 46:155–163

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilski R, Dąbkowski S, Kozieł I, Kozicki M, Małachowska A, Przygocki M, Tyska O (2025) Perspectives on Alzheimer’s disease treatment based on counteracting oxidative stress. Biomolecules. https://doi.org/10.3390/biom15091345

Article  PubMed  PubMed Central  Google Scholar 

Caldarelli M, Rio P, Marrone A, Ocarino F, Chiantore M, Candelli M, Gasbarrini A, Gambassi G, Cianci R (2024) Gut–brain axis: focus on sex differences in neuroinflammation. Int J Mol Sci 25(10):5377

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cauli O (2021) Oxidative stress and cognitive alterations induced by cancer chemotherapy drugs: a scoping review. Antioxidants 10(7):1116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cham ED, Peng T-I, Jou M-J (2024) Pathological role of high sugar in mitochondrial respiratory chain defect-augmented mitochondrial stress. Biology 13(8):639

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Yi Y, Chen B, Zhang H, Dong M, Yuan L, Zhou H, Jiang H, Ma Z (2024) Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology 503:153757. https://doi.org/10.1016/j.tox.2024.153757

Article  CAS  PubMed  Google Scholar 

Chen W, Johnston IN (2025) A systematic review of the neurobiological mechanisms of chemotherapy-induced deficits in executive functions. Brain Behav Immun - Health. https://doi.org/10.1016/j.bbih.2025.101161

Article  PubMed  PubMed Central  Google Scholar 

Chen W, Yu Y, Liu Y, Song C, Chen H, Tang C, Song Y, Zhang X (2022) Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats. PLoS One 17(11):e0277061

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu X, Liu Y, Li Y, Li D, Mei Z, Deng Y (2025) Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies. Cell Death Dis 16(1):652. https://doi.org/10.1038/s41419-025-07936-y

Article  PubMed  PubMed Central  Google Scholar 

Chevalier C, Fouqueray P, Bolze S (2023) Imeglimin: a clinical pharmacology review. Clin Pharmacokinet 62(10):1393–1411. https://doi.org/10.1007/s40262-023-01301-y

Article  CAS  PubMed  Google Scholar 

Chevalier C, Perrimond-Dauchy S, Dubourg J, Fouqueray P, Bolze S (2020) Lack of drug-drug interaction between Cimetidine, a renal transporter inhibitor, and Imeglimin, a novel oral antidiabetic drug, in healthy volunteers. Eur J Drug Metab Pharmacokinet 45(6):725–733. https://doi.org/10.1007/s13318-020-00642-4

Article  CAS  PubMed  Google Scholar 

Chew V, Chuang C-H, Hsu C (2024) Translational research on drug development and biomarker discovery for hepatocellular carcinoma. J Biomed Sci 31(1):22. https://doi.org/10.1186/s12929-024-01011-y

Article  PubMed  PubMed Central  Google Scholar 

Chine VB, Au NPB, Ma CHE (2019) Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy. Neurobiol Dis 130:104492. https://doi.org/10.1016/j.nbd.2019.104492

Article  CAS  PubMed  Google Scholar 

Chow J, Lim W, Li L, Yu Q, Zhong Y, Wang Z, Shah SAA, Zhu C, Yan S, Liu H, Hu X, Gao L, Wang S, Liu J, Ma G (2025) Evaluation and comparison of efficacy and safety of mitochondrial modulator (Imeglimin) and DPP-4 inhibitors in patients with type 2 diabetes mellitus: a bayesian network meta-analysis. J Endocrinol Invest. https://doi.org/10.1007/s40618-025-02655-9

Article  PubMed  Google Scholar 

Chughtai S, Doyle D, Tata S, Ram D, Oymagil I (2025) Chemotherapy-induced cognitive impairment: mechanisms, emerging biomarkers, and therapeutic interventions. Biochem Biophys Res Commun 779:152456. https://doi.org/10.1016/j.bbrc.2025.152456

Article  CAS  PubMed